Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Cheminant, Morgane
[Clear All Filters]
2024
Houot R
,
Bachy E
,
Cartron G
,
Gros F-X
,
Morschhauser F
,
Obéric L
,
Gastinne T
,
Feugier P
,
Duléry R
,
Thieblemont C
, et al.
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nat Med. 2024.
PubMed
Google Scholar
Camus V
,
Thieblemont C
,
Gaulard P
,
Cheminant M
,
Casasnovas R-O
,
Ysebaert L
,
Damaj GLaurent
,
Guidez S
,
Pica GMatteo
,
Kim WSeog
, et al.
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
J Clin Oncol. 2024:JCO2301687.
PubMed
Google Scholar
2023
Houot R
,
Bachy E
,
Cartron G
,
Gros F-X
,
Morschhauser F
,
Obéric L
,
Gastinne T
,
Feugier P
,
Duléry R
,
Thieblemont C
, et al.
Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial.
Nat Med. 2023.
PubMed
Google Scholar
Sarkozy C
,
Thieblemont C
,
Obéric L
,
Moreau A
,
Bouabdallah K
,
Damaj G
,
Gastinne T
,
Tessoulin B
,
Ribrag V
,
Casasnovas O
, et al.
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
J Clin Oncol. 2023:JCO2301586.
PubMed
Google Scholar
Houot R
,
Bachy E
,
Cartron G
,
Gros F-X
,
Morschhauser F
,
Obéric L
,
Gastinne T
,
Feugier P
,
Duléry R
,
Thieblemont C
, et al.
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nat Med. 2023.
PubMed
Google Scholar
2022
Cheminant M
,
Fox TA
,
Alligon M
,
Bouaziz O
,
Neven B
,
Moshous D
,
Blanche S
,
Guffroy A
,
Fieschi C
,
Malphettes M
, et al.
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity.
Blood. 2022.
PubMed
Google Scholar
Hermine O
,
Jiang L
,
Walewski J
,
Bosly A
,
Thieblemont C
,
Szymczyk M
,
Pott C
,
Salles G
,
Feugier P
,
Hübel K
, et al.
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
J Clin Oncol. 2022:JCO2201780.
PubMed
Google Scholar